Dr. Falk Pharma Gmbh v. Generico, LLC, Flat Line Capital LLC, Mylan Pharmaceuticals Inc.

N OTE: This disposition is nonprecedential.
United States Court of Appeals
for the Federal Circuit
______________________
July 11, 2019
ERRATUM
______________________
Appeal No. 2017-2312
DR. FALK PHARMA GMBH,
Appellant
v.
GENERICO, LLC, FLAT LINE CAPITAL LLC,
MYLAN PHARMACEUTICALS INC.,
Appellees
--------------------------------------------------
Appeal Nos. 2017-2636, 2018-1320
SALIX PHARMACEUTICALS, INC., DR. FALK
PHARMA GMBH,
Plaintiffs-Appellants
v.
MYLAN PHARMACEUTICALS INC., MYLAN INC.,
Defendants-Appellees
Decided June 12, 2019
Nonprecedential Opinion

-- 1 of 2 --

DR. FALK PHARMA GMBH v. GENERICO, LLC 2
______________________
The following change has been made:
Page 16, line 16, “district court” has been changed to
“Board.”

-- 2 of 2 --